Related Experiment Video
Updated: Jan 9, 2026

Mapping Dysfunctional Protein-Protein Interactions in Disease
Published on: October 24, 2025
Folliculin-interacting protein 1: From molecular structure to disease and therapeutic targets
Youxin Liang1, Guixia Zhang1, Xintian Chen1
1Department of Gastroenterology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524001, China.
Abstract:
Folliculin-interacting protein 1 (FNIP1), a key factor in metabolic regulation networks, has emerged as a focal point in biomedical research. It not only orchestrates energy homeostasis through multiple core signaling pathways but also influences cell fate determination and disease pathogenesis. Although early studies have partially elucidated the mechanisms of FNIP1, whether it can serve as a drug-therapy target for diseases remains inadequately characterized. This review summarizes the recent research progress of FNIP1, focusing on structural determinants that govern its functional plasticity, metabolic pathways modulated by FNIP1-mediated crosstalk, and pathological manifestations resulting from dysregulation of FNIP1. It specifically emphasizes the protein structural basis of FNIP1 as a therapeutic target for diseases such as neurodegenerative diseases, type 2 diabetes, and tumors, as well as the potential for developing FNIP1-related targeted drugs. We aim to construct a conceptual framework for developing precision therapeutic strategies targeting FNIP1-centric regulatory nodes by establishing functional correlations between FNIP1 and other metabolic regulators.
Insights
Folliculin-interacting protein 1 (FNIP1) is crucial for metabolic regulation and influences various diseases. This review highlights FNIP1's structure and potential as a therapeutic target for conditions like diabetes and cancer.
Area of Science:
- Biochemistry
- Molecular Biology
- Metabolic Research
Background:
- Folliculin-interacting protein 1 (FNIP1) plays a vital role in metabolic regulation and cellular processes.
- Its involvement in energy homeostasis, cell fate, and disease pathogenesis is increasingly recognized.
- The therapeutic potential of FNIP1 remains underexplored.
Purpose of the Study:
- To review recent advancements in FNIP1 research.
- To explore the structural basis of FNIP1's function and its role in disease.
- To evaluate FNIP1 as a potential drug-therapy target.
Main Methods:
- Literature review of recent studies on FNIP1.
- Analysis of structural determinants influencing FNIP1 function.
- Examination of metabolic pathways and pathological conditions linked to FNIP1 dysregulation.
Main Results:
- FNIP1 exhibits functional plasticity influenced by its structure.
- FNIP1 modulates key metabolic pathways through crosstalk with other regulators.
- Dysregulation of FNIP1 is associated with neurodegenerative diseases, type 2 diabetes, and tumors.
Conclusions:
- FNIP1's structure provides a basis for its therapeutic targeting.
- Developing FNIP1-related drugs holds promise for treating metabolic and other diseases.
- Establishing functional correlations can guide precision therapeutic strategies targeting FNIP1.
More Related Videos
Related Concept Videos
Structural Protein Function
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...
Protein-protein Interfaces
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Cytoskeletal Linker Proteins - Plakins
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...

